|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/683 | |
| A61P 3/00 | |||
| A61P 9/00 |
| (11) | Number of the document | 2493478 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10825905.2 |
| Date of filing the European patent application | 2010-10-29 | |
| (97) | Date of publication of the European application | 2012-09-05 |
| (45) | Date of publication and mention of the grant of the patent | 2018-02-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2010/001720 |
| Date | 2010-10-29 |
| (87) | Number | WO 2011/050474 |
| Date | 2011-05-05 |
| (30) | Number | Date | Country code |
| 256106 P | 2009-10-29 | US |
| (72) |
SAMPALIS, Fotini, CA
HARLAND, Henri, CA
|
| (73) |
Acasti Pharma, Inc.,
545 Promenade du Centropolis, Suite 100, Laval, Quebec H7T 0A3,
CA
|
| (54) | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS |
| CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS |